Navigation Links
Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes
Date:12/16/2009

CAMBRIDGE, Mass., Dec. 16 /PRNewswire/ -- Sermo (http://www.sermo.com), the world's largest online community for physicians, today announced the results of a new Sermo Vitals Report titled "Diabetes: MD Social Media Conversations." The report examines physician dialog about diabetes over a one-year period and provides a complete analysis of a variety of topics, including the therapies physicians discuss most frequently, the brands they prefer, and candid/verbatim comments on issues related to diabetes.

Leveraging Sermo's social media platform, the report examines more than 4,600 comments generated by 1,531 physicians from 11/08-10/09 and measures changes in physician sentiment and perceptions over this time period.

The report covers the following diabetes topics:

  • Physician concerns about the cost and affordability of treatment options
  • How prescribing decisions are shaped
  • Top medications discussed and prescribed
  • Approaches to patient education and lifestyle coaching
  • Worries about long-term health risks and complications

Diabetes is the 3rd most discussed disease state within the Sermo community. Through this report, organizations now have a looking glass into the organic, peer-to-peer discussions physicians have about diabetes every day.

Top companies and medications discussed and analyzed in this report include Byetta (Amylin and Lilly), Metformin, Liraglutide (Novo Nordisk), VIAject (Biodel), Avandia (GlaxoSmithKline), Januvia (Merck), Onglyza (AstraZeneca Bristol-Myers Squibb), Lantus (sanofi-aventis), Humalog (Lilly), and Actos (Tekeda).

Visit http://www.sermo.com/diabetes or call 877-778-3963 to view the full report.

About Sermo Vital Reports:

Sermo Vital Reports mine organic physicians conversations about drugs, therapeutic areas, disease states and more. This is only possible through Sermo's social media platform, which allows physicians nationwide to collaborate and exchange observations about drugs, devices and clinical issues - entirely online. Through a unique set of social media tools, Sermo taps into this dialog to quantify the impact of conversations as they unfold.

Each Sermo Vital Report includes both quantitative and qualitative insight from real-world physician conversations. Reports are in PowerPoint format and include full discussion analysis. All physicians on Sermo are verified and credentialed, ensuring they have valid, active licenses to practice medicine in the United States. Visit www.sermo.com/diabetes to learn more.

About Sermo

Sermo is the largest online physician community in the US. It's where over 110,000 practicing physicians collaborate on difficult cases and exchange observations about drugs, devices and clinical issues. Through a unique set of social media tools, Sermo provides access to its community for organizations that need fast, actionable MD insights into treatments, drugs and devices. Visit http://www.sermo.com to learn more.

SOURCE Sermo


'/>"/>
SOURCE Sermo
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Emergency Preparedness Simulation Scenarios Developed for Disaster Training Utilizing Laerdals VitalSim(TM) Product Line
2. New Health Monitoring and Health Tracking Website, VitalsTracker.com, Helps Health Consumers Organize Important Medical Data
3. Vitals Reports Thousands of Americans Are Checking Up on Dr. Sanjay Gupta
4. Vitals Launches Free eBook to Help Consumers Find "Dr. Right"
5. Vitals Launches Free eBook to Help Consumers Find Dr. Right
6. Alliance for Wellness ROI, Inc. Selects VitalSpring as Exclusive Technology Partner
7. Dr. Robert CJ Krasner Appointed to Vitals.com as Independent Advisor
8. Vitals.com Goes Red for American Heart Month
9. MWW Group Selected by First-Ever Online Doctor Evaluation Service Vitals.com
10. Study quantifies racial disparities in cancer mortality rates between blacks and whites
11. University of Michigan, Blue Care Network Study Quantifies Health Care Savings of Regular Dental Care for Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: